Astrix Technology LLC
UEI NRVNN8E6NCK4 · NJ · subsidiary of Astrix Technology, LLC · SAM.gov record ↗
Obligations by agency
- Department Of Health And Human Services$23.3M
- Department Of Agriculture$857K
- General Services Administration$0
Obligations by NAICS
Monthly obligations
Contracts ending within 18 months (recompete watch)
- 75N98024F00012 ↗$169K
ASTRIX TECHNOLOGY, LLC:1204486 [24-002711] SUSTAINED SUPPORT UNDER TASK ORDER 75N98024F00012 IS INDISPENSABLE TO ENSURING UNINTERRUPTED PROGRESS ON CRITICAL, MISSION-DRIVEN RESEARCH WITHIN THE NIDCD SECTION ON SENSORY CELL BIOLOGY.
- Ends
- Sep 5, 2026
- Started
- Sep 25, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98023F00011 ↗$193K
ASTRIX TECHNOLOGY, LLC:1204486 [23-001994] SUSTAINED SUPPORT UNDER TASK ORDER 75N98023F00011 IS CRITICAL TO ENSURING THE UNINTERRUPTED ADVANCEMENT OF MISSION-DRIVEN RESEARCH WITHIN THE NIDCD AUDITORY DEVELOPMENT AND RESTORATION PROGRAM.
- Ends
- Sep 7, 2026
- Started
- Sep 8, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98023F00010 ↗$165K
ONE FEDERAL SOLUTION CORPORATION:1356106 [23-001993] SUSTAINED SUPPORT UNDER TASK ORDER 75N98023F00010 IS ESSENTIAL TO MAINTAINING THE UNINTERRUPTED PROGRESS OF CRITICAL RESEARCH WITHIN THE NIDCD SECTION ON SENSORY CELL BIOLOGY.
- Ends
- Sep 7, 2026
- Started
- Sep 8, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N93025F00001 ↗$177K
ASTRIX TECHNOLOGY, LLC:1204486 [25-004764]- BUDGET ANALYST
- Ends
- Sep 15, 2026
- Started
- Sep 16, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N93025F90012 ↗$192K
ASTRIX TECHNOLOGY, LLC:1204486 [25-003325]- STAFF CLINICIAN
- Ends
- Sep 21, 2026
- Started
- Sep 22, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98C26F00001 ↗$20K
THIS IS FOR DIRECT COSTS (CONFERENCES, REGISTRATION, TRAVEL) INCURRED AS A RESULT OF EXECUTING CALL ORDERS UNDER THE NIDCD / ASTRIX BPA (75N98022A00041). THIS WILL COVER SCIENTIFIC MEETINGS INCLUDING THE UPCOMING 2026 ARO MID-WINTER CONFERENCE .
- Ends
- Sep 24, 2026
- Started
- Sep 25, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N94025F00053 ↗$143K
NIAAA: SERVICE: PROGRAM MANAGER - SEVERABLE
- Ends
- Sep 27, 2026
- Started
- Sep 28, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98025F00282 ↗$118K
ASTRIX TECHNOLOGY, LLC:1204486 [25-002883]
- Ends
- Sep 27, 2026
- Started
- Sep 28, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98026F00007 ↗$124K
NIAAA: SERVICE: CLINICAL RESEARCH ASSOCIATE - SEVERABLE
- Ends
- Oct 17, 2026
- Started
- Apr 19, 2026
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98025F00002 ↗$205K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [25-000004] BIOLOGIST
- Ends
- Oct 25, 2026
- Started
- Oct 27, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541712
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N98024F00012 ↗ | ASTRIX TECHNOLOGY, LLC:1204486 [24-002711] SUSTAINED SUPPORT UNDER TASK ORDER 75N98024F00012 IS INDISPENSABLE TO ENSURING UNINTERRUPTED PROGRESS ON CRITICAL, MISSION-DRIVEN RESEARCH WITHIN THE NIDCD SECTION ON SENSORY CELL BIOLOGY. | National Institutes Of Health | 541712 | $169K | Sep 25, 2024 | Sep 5, 2026 |
| 75N98023F00011 ↗ | ASTRIX TECHNOLOGY, LLC:1204486 [23-001994] SUSTAINED SUPPORT UNDER TASK ORDER 75N98023F00011 IS CRITICAL TO ENSURING THE UNINTERRUPTED ADVANCEMENT OF MISSION-DRIVEN RESEARCH WITHIN THE NIDCD AUDITORY DEVELOPMENT AND RESTORATION PROGRAM. | National Institutes Of Health | 541712 | $193K | Sep 8, 2023 | Sep 7, 2026 |
| 75N98023F00010 ↗ | ONE FEDERAL SOLUTION CORPORATION:1356106 [23-001993] SUSTAINED SUPPORT UNDER TASK ORDER 75N98023F00010 IS ESSENTIAL TO MAINTAINING THE UNINTERRUPTED PROGRESS OF CRITICAL RESEARCH WITHIN THE NIDCD SECTION ON SENSORY CELL BIOLOGY. | National Institutes Of Health | 541712 | $165K | Sep 8, 2023 | Sep 7, 2026 |
| 75N93025F00001 ↗ | ASTRIX TECHNOLOGY, LLC:1204486 [25-004764]- BUDGET ANALYST | National Institutes Of Health | 541712 | $177K | Sep 16, 2025 | Sep 15, 2026 |
| 75N93025F90012 ↗ | ASTRIX TECHNOLOGY, LLC:1204486 [25-003325]- STAFF CLINICIAN | National Institutes Of Health | 541712 | $192K | Sep 22, 2025 | Sep 21, 2026 |
| 75N98C26F00001 ↗ | THIS IS FOR DIRECT COSTS (CONFERENCES, REGISTRATION, TRAVEL) INCURRED AS A RESULT OF EXECUTING CALL ORDERS UNDER THE NIDCD / ASTRIX BPA (75N98022A00041). THIS WILL COVER SCIENTIFIC MEETINGS INCLUDING THE UPCOMING 2026 ARO MID-WINTER CONFERENCE . | National Institutes Of Health | 541712 | $20K | Sep 25, 2023 | Sep 24, 2026 |
| 75N94025F00053 ↗ | NIAAA: SERVICE: PROGRAM MANAGER - SEVERABLE | National Institutes Of Health | 541712 | $143K | Sep 28, 2025 | Sep 27, 2026 |
| 75N98025F00282 ↗ | ASTRIX TECHNOLOGY, LLC:1204486 [25-002883] | National Institutes Of Health | 541712 | $118K | Sep 28, 2025 | Sep 27, 2026 |
| 75N98026F00007 ↗ | NIAAA: SERVICE: CLINICAL RESEARCH ASSOCIATE - SEVERABLE | National Institutes Of Health | 541712 | $124K | Apr 19, 2026 | Oct 17, 2026 |
| 75N98025F00002 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [25-000004] BIOLOGIST | National Institutes Of Health | 541712 | $205K | Oct 27, 2024 | Oct 25, 2026 |
Largest awards
- 75N92023F00070 ↗$2.9M
PROFESSIONAL SUPPORT SERVICES FOR THE NHLBI DIVISION OF INTRAMURAL RESEARCH (DIR)
- Ends
- Feb 27, 2027
- Started
- Feb 28, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 12639524F0248 ↗$770K
PHASE V OF THE LABVANTAGE LIMS SYSTEM
- Ends
- Oct 27, 2025
- Started
- Jan 28, 2024
- Agency
- Animal And Plant Health Inspection Service
- NAICS
- 541712
- 75N98026F00181 ↗$542K
LABORATORY TESTING - CELL THERAPY MANUFACTURING
- Ends
- Jun 5, 2027
- Started
- Jun 7, 2026
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N90025F00041 ↗$530K
BIOMEDICAL SCIENTIFIC RESEARCHERS
- Ends
- Jun 6, 2026
- Started
- Jun 8, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98024F00006 ↗$473K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-000407] SCIENTIFIC RESEARCHER SR
- Ends
- Nov 23, 2026
- Started
- Nov 24, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98024F00024 ↗$420K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-003020] BIOLOGIST OPTION RENEWAL
- Ends
- May 30, 2027
- Started
- May 31, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98024F00008 ↗$410K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-000245] RESEARCH ASSOCIATE
- Ends
- Dec 13, 2026
- Started
- Dec 14, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98026F00005 ↗$393K
NIAID ASTRIX CONTRACT (75N98022A00040) TWO PROJECT MANAGERS - SENIOR PROPERTY SPECIALISTS (20260209-NEI001(SMITH), 20260209-NEI002 (PARADA-MEJIA), POP: 4/1/26 - 3/31/27
- Ends
- Apr 25, 2027
- Started
- Apr 26, 2026
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98024F00009 ↗$387K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-000613] STAFF CLINICIAN
- Ends
- Jan 2, 2027
- Started
- Jan 3, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98025F00002 ↗$371K
ASTRIX TECHNOLOGY, LLC:1204486 [25-000063] SCIENTIFIC SR.
- Ends
- Dec 20, 2026
- Started
- Nov 3, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98024F00005 ↗$371K
ASTRIX TECHNOLOGY, LLC:1204486 [24-001347] BIOLOGIST FOR NIDCD NEEDING OPTION ONE TO BE EXERCISED THRU 4/26/26.
- Ends
- Apr 25, 2027
- Started
- Apr 28, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98023F00049 ↗$356K
ASTRIX TECHNOLOGY, LLC:1204486 [23-003007] THIS BPA CALL MOD IS TO EXERCISE OPTION YEAR TWO FOR NEI CONTRACTOR - GENETIC COUNSELOR THRU 5/15.26. THIS ALIGNS WITH TWO EXEMPTIONS: ITEMS RELATED TO HUMAN SAFETY, HUMAN OR ANIMAL HEALTHCARE, SECURITY, BI
- Ends
- May 14, 2027
- Started
- May 15, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98023F00045 ↗$348K
ASTRIX TECHNOLOGY, LLC:1204486 [23-003116] PROGRAM MANAGER - THIS MOD IS TO EXERCISE OPTION YEAR TWO FOR NEI OFFICE OF DATA SCIENCE AND HEALTH INFORMATICS THAT OPERATES TWO HIGH-PROFILE, HIGH-VALUE PARTICIPANT REGISTRIES, EYEGENE (THE NATIONAL OPHTHA
- Ends
- Apr 29, 2027
- Started
- Apr 30, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98024F00022 ↗$343K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-003115] BIOSTATISTICIAN
- Ends
- Apr 26, 2027
- Started
- Apr 28, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98024F00007 ↗$334K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-000779] MANAGER
- Ends
- Nov 30, 2026
- Started
- Dec 3, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98026F00062 ↗$332K
26-002918 SCIENTIFIC RESEARCHER JR (2) (CELL ENGINEER) PERIOD OF PERFORMANCE 03/30/2026 TO 03/29/2027
- Ends
- Mar 28, 2027
- Started
- Mar 29, 2026
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98023F00052 ↗$329K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [23-003853] THE IMPACT OF OPTION TWO LAPSING WOULD BE DETRIMENTAL TO ONGOING CLINICAL SERVICES FOR PATIENTS BEING SEEN ACROSS THE NIH.
- Ends
- Jun 29, 2027
- Started
- Jun 30, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98023F00064 ↗$329K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [23-004966] PROGRAM MANAGER
- Ends
- Dec 28, 2026
- Started
- Sep 10, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98023F00041 ↗$315K
ASTRIX TECHNOLOGY, LLC:1204486 [23-002283] OPERATIONS/PROJECT MANAGER - THIS MOD IS TO EXERCISE OPTION YEAR TWO OF THE CONTRACT THRU 5/11/26. EXERCISING OF OPTION TWO IS NECESSARY TO PREVENT A LOSS OF SIGNIFICANT INVESTMENTS DEVOTED TO THIS CONTRACT
- Ends
- May 10, 2027
- Started
- Apr 11, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98023F00065 ↗$309K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [23-005055] SCIENTIFIC RESEARCHER
- Ends
- Nov 25, 2026
- Started
- Sep 17, 2023
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98025F00006 ↗$309K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [25-001147] PROJECT MANAGER
- Ends
- Jan 9, 2027
- Started
- Jan 10, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N92025F00049 ↗$288K
ASTRIX REGULATORY AND CLINICAL TRIALS MANAGER
- Ends
- Feb 4, 2026
- Started
- Feb 5, 2025
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98024F00014 ↗$272K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-001531] EXERCISE OPTION ONE FOR DR. VENDRA TO CONTINUE DR. HEJTMANCIK'S STUDIES OF BETAGAMMA-CRYSTALIN MUTATIONS AND THEIR EFFECT ON THE PROTEIN STRUCTURE AND STABILITY AND ITS EFFECT ON LENS HOMEOSTAT
- Ends
- Apr 24, 2027
- Started
- Jan 28, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98024F00018 ↗$271K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-001352] RESEARCH ASSOCIATE
- Ends
- Feb 13, 2027
- Started
- Feb 14, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541712
- 75N98024F00020 ↗$249K
ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-001755] SCIENTIFIC RESEARCHER
- Ends
- Mar 5, 2027
- Started
- Mar 6, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541712
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N92023F00070 ↗ | PROFESSIONAL SUPPORT SERVICES FOR THE NHLBI DIVISION OF INTRAMURAL RESEARCH (DIR) | National Institutes Of Health | 541712 | $2.9M | Feb 28, 2023 | Feb 27, 2027 |
| 12639524F0248 ↗ | PHASE V OF THE LABVANTAGE LIMS SYSTEM | Animal And Plant Health Inspection Service | 541712 | $770K | Jan 28, 2024 | Oct 27, 2025 |
| 75N98026F00181 ↗ | LABORATORY TESTING - CELL THERAPY MANUFACTURING | National Institutes Of Health | 541712 | $542K | Jun 7, 2026 | Jun 5, 2027 |
| 75N90025F00041 ↗ | BIOMEDICAL SCIENTIFIC RESEARCHERS | National Institutes Of Health | 541712 | $530K | Jun 8, 2025 | Jun 6, 2026 |
| 75N98024F00006 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-000407] SCIENTIFIC RESEARCHER SR | National Institutes Of Health | 541712 | $473K | Nov 24, 2023 | Nov 23, 2026 |
| 75N98024F00024 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-003020] BIOLOGIST OPTION RENEWAL | National Institutes Of Health | 541712 | $420K | May 31, 2024 | May 30, 2027 |
| 75N98024F00008 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-000245] RESEARCH ASSOCIATE | National Institutes Of Health | 541712 | $410K | Dec 14, 2023 | Dec 13, 2026 |
| 75N98026F00005 ↗ | NIAID ASTRIX CONTRACT (75N98022A00040) TWO PROJECT MANAGERS - SENIOR PROPERTY SPECIALISTS (20260209-NEI001(SMITH), 20260209-NEI002 (PARADA-MEJIA), POP: 4/1/26 - 3/31/27 | National Institutes Of Health | 541712 | $393K | Apr 26, 2026 | Apr 25, 2027 |
| 75N98024F00009 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-000613] STAFF CLINICIAN | National Institutes Of Health | 541712 | $387K | Jan 3, 2024 | Jan 2, 2027 |
| 75N98025F00002 ↗ | ASTRIX TECHNOLOGY, LLC:1204486 [25-000063] SCIENTIFIC SR. | National Institutes Of Health | 541712 | $371K | Nov 3, 2024 | Dec 20, 2026 |
| 75N98024F00005 ↗ | ASTRIX TECHNOLOGY, LLC:1204486 [24-001347] BIOLOGIST FOR NIDCD NEEDING OPTION ONE TO BE EXERCISED THRU 4/26/26. | National Institutes Of Health | 541712 | $371K | Apr 28, 2024 | Apr 25, 2027 |
| 75N98023F00049 ↗ | ASTRIX TECHNOLOGY, LLC:1204486 [23-003007] THIS BPA CALL MOD IS TO EXERCISE OPTION YEAR TWO FOR NEI CONTRACTOR - GENETIC COUNSELOR THRU 5/15.26. THIS ALIGNS WITH TWO EXEMPTIONS: ITEMS RELATED TO HUMAN SAFETY, HUMAN OR ANIMAL HEALTHCARE, SECURITY, BI | National Institutes Of Health | 541712 | $356K | May 15, 2023 | May 14, 2027 |
| 75N98023F00045 ↗ | ASTRIX TECHNOLOGY, LLC:1204486 [23-003116] PROGRAM MANAGER - THIS MOD IS TO EXERCISE OPTION YEAR TWO FOR NEI OFFICE OF DATA SCIENCE AND HEALTH INFORMATICS THAT OPERATES TWO HIGH-PROFILE, HIGH-VALUE PARTICIPANT REGISTRIES, EYEGENE (THE NATIONAL OPHTHA | National Institutes Of Health | 541712 | $348K | Apr 30, 2023 | Apr 29, 2027 |
| 75N98024F00022 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-003115] BIOSTATISTICIAN | National Institutes Of Health | 541712 | $343K | Apr 28, 2024 | Apr 26, 2027 |
| 75N98024F00007 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-000779] MANAGER | National Institutes Of Health | 541712 | $334K | Dec 3, 2023 | Nov 30, 2026 |
| 75N98026F00062 ↗ | 26-002918 SCIENTIFIC RESEARCHER JR (2) (CELL ENGINEER) PERIOD OF PERFORMANCE 03/30/2026 TO 03/29/2027 | National Institutes Of Health | 541712 | $332K | Mar 29, 2026 | Mar 28, 2027 |
| 75N98023F00052 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [23-003853] THE IMPACT OF OPTION TWO LAPSING WOULD BE DETRIMENTAL TO ONGOING CLINICAL SERVICES FOR PATIENTS BEING SEEN ACROSS THE NIH. | National Institutes Of Health | 541712 | $329K | Jun 30, 2023 | Jun 29, 2027 |
| 75N98023F00064 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [23-004966] PROGRAM MANAGER | National Institutes Of Health | 541712 | $329K | Sep 10, 2023 | Dec 28, 2026 |
| 75N98023F00041 ↗ | ASTRIX TECHNOLOGY, LLC:1204486 [23-002283] OPERATIONS/PROJECT MANAGER - THIS MOD IS TO EXERCISE OPTION YEAR TWO OF THE CONTRACT THRU 5/11/26. EXERCISING OF OPTION TWO IS NECESSARY TO PREVENT A LOSS OF SIGNIFICANT INVESTMENTS DEVOTED TO THIS CONTRACT | National Institutes Of Health | 541712 | $315K | Apr 11, 2023 | May 10, 2027 |
| 75N98023F00065 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [23-005055] SCIENTIFIC RESEARCHER | National Institutes Of Health | 541712 | $309K | Sep 17, 2023 | Nov 25, 2026 |
| 75N98025F00006 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [25-001147] PROJECT MANAGER | National Institutes Of Health | 541712 | $309K | Jan 10, 2025 | Jan 9, 2027 |
| 75N92025F00049 ↗ | ASTRIX REGULATORY AND CLINICAL TRIALS MANAGER | National Institutes Of Health | 541712 | $288K | Feb 5, 2025 | Feb 4, 2026 |
| 75N98024F00014 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-001531] EXERCISE OPTION ONE FOR DR. VENDRA TO CONTINUE DR. HEJTMANCIK'S STUDIES OF BETAGAMMA-CRYSTALIN MUTATIONS AND THEIR EFFECT ON THE PROTEIN STRUCTURE AND STABILITY AND ITS EFFECT ON LENS HOMEOSTAT | National Institutes Of Health | 541712 | $272K | Jan 28, 2024 | Apr 24, 2027 |
| 75N98024F00018 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-001352] RESEARCH ASSOCIATE | National Institutes Of Health | 541712 | $271K | Feb 14, 2024 | Feb 13, 2027 |
| 75N98024F00020 ↗ | ASTRIX SOFTWARE TECHNOLOGY, INC:1204486 [24-001755] SCIENTIFIC RESEARCHER | National Institutes Of Health | 541712 | $249K | Mar 6, 2024 | Mar 5, 2027 |